Full-text resources of CEJSH and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

Results found: 1

first rewind previous Page / 1 next fast forward last

Search results

help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
1
Publication available in full text mode
Content available

Kontrowersje związane z reklamowaniem leków Analiza porównawcza Polski i Stanów Zjednoczonych

100%
Makowska M., Warsaw University of Life Sciences, marta_makowska@sggw.pl
Annales. Etyka w Życiu Gospodarczym
|
2016
|
vol. 19
|
issue 3
EN
For many years, the subject of aggressive marketing campaigns conducted by pharmaceutical companies has been raised in Poland. Drug ads are everywhere, on television, the radio, magazines and on the Internet. Therefore, it is extremely important is to ensure both their legal and ethical dimension. In my article I will present the differences between direct-to-consumer advertising of medicines in Poland and in the US. The dissimilarities result mainly from differences in legislation. In Poland the law is much stricter than in the US. For example, in the United States companies are allowed to advertise prescription drugs directly to patients. In the whole of the European Union, and thus in Poland, it is strictly prohibited. The article will present other regulations existing in Poland and in the United States and it will compare them. It will show examples of violations of the law and ethics in the advertising of medicine in both countries. It will briefly outline the negative consequences of unacceptable pharmaceutical marketing.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.